CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Revenues:
Revenue, net	$ 11,588	$ 7,447
Costs and expenses:
Cost of revenues	12,799	8,610
Selling, general and administrative expenses	6,272	6,717
Impairment charges	24	8,373
Product development and research expenses	1,463	1,800
Total costs and expenses	20,558	25,500
Operating loss	(8,970)	(18,053)
Other Expense:
Foreign currency exchange loss	(2,092)	(1,597)
Interest and other expense, net	(4,119)	(5,876)
Gain on debt restructuring	22,439	0
Inducement loss	(1,889)	0
Change in the fair value of derivative liabilities	(3,186)	(1,258)
Income/(loss) before income tax expense	2,183	(26,784)
Income tax expense	30	52
Net income/(loss) attributable to common shareholders	$ 2,153	$ (26,836)
Earnings Per Share [Abstract]
Basic income/(loss) per share (in dollars per share)	$ 0.04	$ (4.98)
Diluted income/(loss) per share (in dollars per share)	$ 0.03	$ (4.98)
Weighted average shares of common stock outstanding:
Basic (in shares)	58,472,427	5,387,933
Diluted (in shares)	77,142,350	5,387,933